FDA label
What is Vyvanse used for?
Vyvanse contains lisdexamfetamine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “VYVANSE® is indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older; Moderate to severe binge eating disorder (BED) in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Vyvanse?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Vyvanse, capsule
Indications and Usage, quoted from the label by Takeda Pharmaceuticals America, Inc. (NDA021977). Cross-references to other label sections are left out.
VYVANSE® is indicated for the treatment of:
- Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
- Moderate to severe binge eating disorder (BED) in adults.
Limitations of Use:
- The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.
- VYVANSE is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of VYVANSE for the treatment of obesity have not been established.
Source: DailyMed label, set id 704e4378-ca83-445c-8b45-3cfa51c1ecad, version 81, effective April 30, 2026. NDC 59417-101, one of 7 listings for this product.
Questions
What is Vyvanse used for?
The FDA label says: “VYVANSE® is indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older; Moderate to severe binge eating disorder (BED) in adults.”
What drug class is Vyvanse?
FDA lists lisdexamfetamine in the Central Nervous System Stimulant established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Vyvanse
- Is Vyvanse a controlled substance?Schedule II
- Generic for VyvanseFDA Orange Book
- What is Lisdexamfetamine used for?FDA label uses
- Is Lisdexamfetamine a controlled substance?Schedule II
- Generic for AryntaFDA Orange Book
- Central Nervous System Stimulants listFDA drug class
- NDC 59417-101Vyvanse NDC record
- NDC 59417-102Vyvanse NDC record
- NDC 59417-103Vyvanse NDC record
- Schedule II drugs listDEA schedule